[MUR and MCA: allies to guarantee therapeutic success]

[MUR 和 MCA:确保治疗成功的盟友]

阅读:2

Abstract

A 73-year-old, dependent, polymedicated, multi-pathological patient contacts the Community Pharmacy by telephone to request information on a newly prescribed treatment for a urinary tract infection and vitamin D deficiency. The dispensing of the medication to her caregiver leads to further doubts for the patient, so she is offered the Medication Use Review (MUR) service. During the service, several incidences are detected in her treatment, so it is decided to make a referral report to the Primary Care Physician for a complete review of the treatment and thus be able to refer the patient to the Personalized Dosage System (SPD) service in order to guarantee the patient's pharmacotherapeutic safety and improve her adherence to the treatment. In this case, the provision of the RUM service served as a gateway to the SPD and made it possible to detect Medication Related Problems (MRP) that could lead to therapeutic failure.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。